DaVita
DVA
#2197
Rank
A$12.63 B
Marketcap
A$176.73
Share price
0.09%
Change (1 day)
-29.36%
Change (1 year)
DaVita Inc. is an American company providing dialysis services for patients with chronic and acute kidney failure.

EPS for DaVita (DVA)

EPS in 2025 (TTM): A$15.54

According to DaVita's latest financial reports the company's current EPS (TTM) is A$14.96. In 2024 the company made an earnings per share (EPS) of A$16.61 an increase over its 2023 EPS that were of A$11.46.

EPS history for DaVita from 2012 to 2025

Annual EPS

Year EPS Change
2025 (TTM)A$15.54-6.41%
2024A$16.6144.94%
2023A$11.4627.26%
2022A$9.00-35.56%
2021A$13.9744.1%
2020A$9.7019.7%
2019A$8.10540.48%
2018A$1.26-76.07%
2017A$5.28-19.31%
2016A$6.55242.52%
2015A$1.91-62.87%
2014A$5.1513.43%
2013A$4.548.45%
2012A$4.19

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Tenet Healthcare
THC
A$22.13 47.89%๐Ÿ‡บ๐Ÿ‡ธ USA
Pediatrix Medical Group
MD
A$2.86-80.90%๐Ÿ‡บ๐Ÿ‡ธ USA
Universal Health Services
UHS
A$32.14 114.79%๐Ÿ‡บ๐Ÿ‡ธ USA
LabCorp
LH
A$15.43 3.12%๐Ÿ‡บ๐Ÿ‡ธ USA